Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778154 · ClinicalTrials.gov registry record
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
A clinical trial of Postmenopausal Osteoporosis, sponsored by Warner Chilcott.
- Completed
- Registry status
- 105
- Enrollment target
- 8
- Study locations
NCT00778154: Completed study of Postmenopausal Osteoporosis, sponsored by Warner Chilcott.
NCT00778154 is a study of Postmenopausal Osteoporosis that has completed, run by Warner Chilcott. The registered enrollment target is 105 participants, below the 513-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (80% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00778154, a study of Postmenopausal Osteoporosis, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
- 8
- Study locations
Study Summary
Patients who have received the appropriate number of years of alendronate or risedronate therapy will be recruited. Each patient will have received baseline BMD measurements performed at the spine and the hip by DXA. Each patient will receive tetracycline to label the bone and then have a transiliac bone biopsy. One year later teh bone label and biopsy procedure will be repeated.
Conditions Studied
Study Locations (8)
Georgia
- Warner Chilcott Research Facility - Decatur
- Warner Chilcott Research Facility - Gainesville
California
- Warner Chilcott Research Facility - Palm Desert
Colorado
- Warner Chilcott Research Facility - Lakewood
Nebraska
- Warner Chilcott Research Facility - Omaha
Ohio
- Warner Chilcott Research Facility - Cincinnati
Pennsylvania
- Warner Chilcott Research Facility - Wyomissing
Quebec
- Warner Chilcott Research Facility - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-12 |
What the finished NCT00778154 record still lists
NCT00778154 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 513-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 0 interventions.
NCT00778154 lists 8 locations in 7 states (Georgia, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT00778154 about?
NCT00778154 is a clinical study titled "Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate". Patients who have received the appropriate number of years of alendronate or risedronate therapy will be recruited. Each patient will have received baseline BMD measurements performed at the spine and the hip by DXA. Each patient will receive tetracycline to label the bone and then have a transiliac...
What is the current status of trial NCT00778154?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2004-01. Estimated completion is 2006-12.
What conditions does trial NCT00778154 study?
This clinical trial studies the following conditions: Postmenopausal Osteoporosis.
Who is sponsoring clinical trial NCT00778154?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00778154 being conducted?
This trial has 8 study locations across California, Colorado, Georgia, Nebraska, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopausal Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00778154's enrollment target sits among peer trials
105 12th of 14 higher than 3 of 14 other Postmenopausal Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postmenopausal Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dried Plums and Bone Health in Postmenopausal Women
ACTIVE NOT RECRUITING · NA
-
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
ACTIVE NOT RECRUITING · Phase 2
-
Anabolic Therapy in Postmenopausal Osteoporosis
ACTIVE NOT RECRUITING · Phase 4
-
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
COMPLETED · Phase 3
-
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
COMPLETED · Phase 4
-
A Study of Monthly Risedronate for Osteoporosis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia